Table 1 Absolute and relative changes in annual and monthly incidence count, stage at diagnosis and healthcare pathway to diagnosis from 2019 to 2020, by sex, age group and income area-deprivation quintile for female breast cancer, colorectal cancer and non-small cell lung cancer, Wales, UK.
Female breast cancer N (%) | Colorectal cancer N (%) | Non-small cell lung cancer N (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
2019 | 2020 | Difference | 2019 | 2020 | Difference | 2019 | 2020 | Difference | |
Annual incidence | 2482 (100) | 2008 (100) | −474 (−19.10) | 2221 (100) | 1838 (100) | −383 (−17.24) | 1948 (100) | 1794 (100) | −154 (−7.91) |
Monthly incidence | |||||||||
January | 211 (8.50) | 233 (11.60) | 22 (10.43) | 210 (9.46) | 183 (9.96) | −27 (−12.86) | 187 (9.60) | 204 (11.37) | 17 (9.09) |
February | 182 (7.33) | 182 (9.06) | 0 | 178 (8.01) | 175 (9.52) | −3 (−1.69) | 168 (8.62) | 179 (9.98) | 11 (6.55) |
March | 186 (7.49) | 204 (10.16) | 18 (9.86) | 175 (7.88) | 184 (10.01) | 9 (5.14) | 161 (8.26) | 152 (8.47) | −9 (−5.59) |
April | 190 (7.66) | 104 (5.18) | −86 (−45.26) | 182 (8.19) | 73 (3.97) | −109 (−59.89) | 148 (7.60) | 107 (5.96) | −41 (−27.70) |
May | 232 (9.35) | 119 (5.93) | −113 (−41.85) | 168 (7.56) | 93 (5.06) | −75 (−44.64) | 166 (8.52) | 124 (6.91) | −42 (−15.56) |
June | 190 (7.66) | 135 (6.72) | −55 (−28.37) | 181 (8.15) | 162 (8.81) | −19 (−10.50) | 151 (7.75) | 138 (7.96) | −13 (−4.81) |
July | 260 (10.48) | 148 (7.37) | −112 (−43.48) | 190 (8.55) | 167 (9.09) | −23 (−12.11) | 173 (8.88) | 176 (9.81) | 3 (1.11) |
August | 196 (7.90) | 104 (5.18) | −92 (−46.07) | 185 (8.33) | 146 (7.94) | −39 (−21.08) | 172 (8.83) | 145 (8.08) | −27 (−10.00) |
September | 207 (8.34) | 201 (10.01) | −6 (−2.90) | 195 (8.78) | 155 (8.43) | −40 (−20.51) | 140 (7.19) | 174 (9.70) | 34 (12.59) |
October | 243 (9.79) | 178 (8.86) | −65 (−26.07) | 200 (9.00) | 164 (8.92) | −36 (−18.00) | 188 (9.65) | 144 (8.03) | −44 (−16.30) |
November | 197 (7.94) | 225 (11.21) | 28 (14.37) | 186 (8.37) | 182 (9.90) | −4 (−2.15) | 150 (7.70) | 130 (7.25) | −20 (−7.41) |
December | 188 (7.57) | 175 (8.72) | −13 (−6.81) | 171 (7.70) | 154 (8.38) | −17 (−9.94) | 144 (7.39) | 121 (6.74) | −23 (−8.52) |
Stage at diagnosis | |||||||||
Stage I | 899 (35.95) | 525 (25.99) | −374 (−41.60) | 308 (13.87) | 216 (11.75) | −92 (−29.87) | – | – | – |
Stage II | 984 (39.34) | 782 (38.71) | −202 (−20.53) | 405 (18.24) | 296 (16.10) | −109 (−26.91) | – | – | – |
Stage III | 259 (10.36) | 212 (10.50) | −47 (−18.15) | 946 (42.59) | 681 (37.05) | −265 (−28.01) | – | – | – |
Stage IV | 46 (1.84) | 31 (1.53) | −15 (−32.61) | 534 (24.04) | 392 (21.33) | −142 (−26.59) | – | – | – |
Unknown | 294 (11.76) | 458 (22.67) | 164 (55.78) | 28 (1.26) | 253 (13.76) | 225 (803.57) | – | – | – |
Healthcare pathway to diagnosis | |||||||||
Screening | 943 (37.99) | 492 (24.50) | −451 (−47.83) | 279 (12.56) | 242 (13.17) | −37 (−13.26) | – | – | – |
GP urgent | 1198 (48.27) | 1224 (60.96) | 26 (2.17) | 1072 (48.27) | 859 (46.74) | −213 (−19.87) | 737 (37.85) | 602 (33.56) | −135 (−18.32) |
Emergency | 46 (1.85) | 41 (2.04) | −5 (−10.87) | 488 (21.97) | 450 (24.48) | −38 (−7.79) | 615 (31.59) | 602 (33.56) | −13 (−2.11) |
From in-patient | 105 (4.23) | 126 (6.27) | 21 (20.00) | 201 (9.05) | 132 (7.18) | −69 (−34.33) | 265 (13.61) | 261 (14.55) | −4 (−1.51) |
From out-patient | 117 (4.71) | 99 (4.93) | −18 (−15.38) | 71 (3.20) | 65 (3.54) | −6 (−8.45) | 160 (8.22) | 161 (8.97) | 1 (0.63) |
Other | 67 (2.70) | 26 (1.29) | −41 (−61.19) | 59 (2.66) | 36 (1.96) | −23 (−38.98) | 61 (3.13) | 61 (3.40) | 0 (0.00) |
Not known | 6 (0.24) | 0 (0) | −6 (−100.00) | 52 (2.34) | 54 (2.94) | 2 (3.85) | 110 (5.65) | 107 (5.96) | −3 (−2.73) |
Sex | |||||||||
Male | – | – | – | 1239 (55.79) | 1089 (59.25) | −150 (−12.11) | 1018 (52.29) | 899 (50.11) | −119 (−11.69) |
Female | 2482 (100) | 2008 (100) | −474 (−19.10) | 982 (44.21) | 749 (40.75) | −233 (−23.73) | 930 (47.77) | 895 (49.89) | −35 (−3.76) |
Age | |||||||||
Under 50 | 341 (13.74) | 326 (16.24) | −15 (−4.40) | 132 (5.94) | 114 (6.20) | −18 (−13.64) | 38 (1.95) | 42 (2.34) | 4 (10.53) |
50–69 | 1208 (48.67) | 916 (45.62) | −292 (−24.17) | 767 (34.53) | 658 (35.80) | −109 (−14.21) | 565 (29.02) | 561 (31.27) | −4 (−0.71) |
70–79 | 540 (21.76) | 459 (22.86) | −81 (−15.00) | 744 (33.50) | 605 (32.92) | −139 (−18.68) | 806 (41.40) | 762 (42.47) | −44 (−5.46) |
80+ | 393 (15.83) | 307 (15.29) | −86 (−21.88) | 578 (26.02) | 461 (25.08) | −117 (−20.24) | 539 (27.68) | 429 (23.91) | −110 (−20.41) |
WIMD income | |||||||||
1—least deprived | 557 (22.44) | 420 (20.92) | −137 (−24.60) | 488 (21.97) | 378 (20.57) | −110 (−22.54) | 270 (13.86) | 240 (13.38) | −30 (−11.11) |
2 | 528 (21.27) | 389 (19.37) | −139 (−26.33) | 484 (21.79) | 402 (21.87) | −82 (−16.94) | 341 (17.51) | 300 (16.72) | −41 (−15.19) |
3 | 551 (22.20) | 424 (21.12) | −127 (−23.05) | 438 (19.72) | 358 (19.48) | −80 (−18.26) | 403 (20.69) | 379 (21.13) | −24 (−8.89) |
4 | 446 (17.97) | 431 (21.46) | −15 (−3.36) | 452 (20.35) | 383 (20.84) | −69 (−15.27) | 437 (22.43) | 400 (22.30) | −37 (−13.70) |
5—most deprived | 400 (16.12) | 344 (17.13) | −56 (−20.74) | 359 (16.16) | 317 (17.25) | −42 (−11.70) | 497 (25.51) | 475 (26.48) | −22 (−8.15) |
